Detalhe da pesquisa
1.
AGILE SCORES IN MASLD AND ALD: EXTERNAL VALIDATION AND THEIR UTILITY IN CLINICAL ALGORITHMS.
J Hepatol;
2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789011
2.
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients.
Biomark Res;
12(1): 44, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679739
3.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver Int;
2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573034
4.
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Semin Liver Dis;
44(1): 35-42, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531378
5.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
JAMA;
331(15): 1287-1297, 2024 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512249
6.
Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population.
J Hepatol;
80(6): 846-857, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331324
7.
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology;
79(5): E130-E131, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252803
8.
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis.
Hepatol Commun;
8(2)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285756
9.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Ann Hepatol;
29(1): 101133, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364816
10.
Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD.
J Hepatol;
80(2): e51-e52, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543307
11.
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements.
Hepatology;
79(4): 869-881, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916970
12.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol;
24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
13.
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Contemp Clin Trials;
134: 107352, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802221
14.
Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease.
Environ Int;
180: 108235, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776622
15.
Extracellular vesicles are carriers of adiponectin with insulin-sensitizing and anti-inflammatory properties.
Cell Rep;
42(8): 112866, 2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605533
16.
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease.
Int J Mol Sci;
24(15)2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569608
17.
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Nat Commun;
14(1): 5219, 2023 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633932
18.
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
J Hepatol;
79(5): 1110-1120, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517454
19.
The NAFLD burden on mortality and morbidities in general population: A community-based longitudinal study (NASH-CO study).
Liver Int;
43(10): 2096-2106, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452492
20.
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Lancet Gastroenterol Hepatol;
8(8): 704-713, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290471